Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Factor H autoantibodies in membranoproliferative glomerulonephritis.

Goodship TH, Pappworth IY, Toth T, Denton M, Houlberg K, McCormick F, Warland D, Moore I, Hunze EM, Staniforth SJ, Hayes C, Cavalcante DP, Kavanagh D, Strain L, Herbert AP, Schmidt CQ, Barlow PN, Harris CL, Marchbank KJ.

Mol Immunol. 2012 Oct;52(3-4):200-6. doi: 10.1016/j.molimm.2012.05.009. Epub 2012 Jun 20.

PMID:
22721707
[PubMed - indexed for MEDLINE]
2.

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F.

J Med Genet. 2007 Mar;44(3):193-9. Epub 2006 Oct 3.

PMID:
17018561
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.

Tanuma Y, Ohi H, Hatano M.

Clin Immunol Immunopathol. 1990 Aug;56(2):226-38.

PMID:
2143128
[PubMed - indexed for MEDLINE]
4.

C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.

Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.

Clin Exp Immunol. 1989 Apr;76(1):82-5.

PMID:
2736802
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).

Ohi H, Yasugi T.

Clin Exp Immunol. 1994 Feb;95(2):316-21.

PMID:
8306508
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.

Licht C, Fremeaux-Bacchi V.

Thromb Haemost. 2009 Feb;101(2):271-8. Review.

PMID:
19190809
[PubMed - indexed for MEDLINE]
7.

Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.

Leroy V, Fremeaux-Bacchi V, Peuchmaur M, Baudouin V, Deschênes G, Macher MA, Loirat C.

Pediatr Nephrol. 2011 Mar;26(3):419-24. doi: 10.1007/s00467-010-1734-4. Epub 2010 Dec 25.

PMID:
21188423
[PubMed - indexed for MEDLINE]
8.

Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.

Frémeaux-Bacchi V, Weiss L, Brun P, Kazatchkine MD.

Nephrol Dial Transplant. 1994;9(7):811-4.

PMID:
7970124
[PubMed - indexed for MEDLINE]
9.

Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.

West CD, McAdams AJ.

Am J Kidney Dis. 1998 Mar;31(3):427-34.

PMID:
9506679
[PubMed - indexed for MEDLINE]
10.

Causes of alternative pathway dysregulation in dense deposit disease.

Zhang Y, Meyer NC, Wang K, Nishimura C, Frees K, Jones M, Katz LM, Sethi S, Smith RJ.

Clin J Am Soc Nephrol. 2012 Feb;7(2):265-74. doi: 10.2215/CJN.07900811. Epub 2012 Jan 5.

PMID:
22223606
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.

Abarrategui-Garrido C, Martínez-Barricarte R, López-Trascasa M, de Córdoba SR, Sánchez-Corral P.

Blood. 2009 Nov 5;114(19):4261-71. doi: 10.1182/blood-2009-05-223834. Epub 2009 Sep 10.

PMID:
19745068
[PubMed - indexed for MEDLINE]
Free Article
12.

Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.

Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.

Mol Immunol. 2009 Sep;46(14):2801-7. doi: 10.1016/j.molimm.2009.05.018. Epub 2009 Jul 28. Review.

PMID:
19640589
[PubMed - indexed for MEDLINE]
13.
14.

Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.

Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.

Clin Nephrol. 1982 Nov;18(5):240-6.

PMID:
7151338
[PubMed - indexed for MEDLINE]
15.

Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis.

Strife CF, Prada AL, Clardy CW, Jackson E, Forristal J.

J Pediatr. 1990 May;116(5):S98-102.

PMID:
2329415
[PubMed - indexed for MEDLINE]
16.

Loss of autoantibody activity by alteration in autoantigen.

Spitzer RE, Stitzel AE.

Clin Immunol Immunopathol. 1996 Aug;80(2):211-3.

PMID:
8764567
[PubMed - indexed for MEDLINE]
17.

Detection of C3bBb-stabilizing activity (C3 nephritic factor) in the serum from patients with membranoproliferative glomerulonephritis.

Ohi H, Watanabe S, Fujita T, Seki M, Hatano M.

J Immunol Methods. 1990 Jul 20;131(1):71-6.

PMID:
2380570
[PubMed - indexed for MEDLINE]
18.

Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.

Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ.

Clin J Am Soc Nephrol. 2011 May;6(5):1009-17. doi: 10.2215/CJN.07110810. Epub 2011 Mar 17.

PMID:
21415311
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Significance of C3 nephritic factor (C3NeF) in non-hypocomplementaemic serum with membranoproliferative glomerulonephritis (MPGN).

Ohi H, Watanabe S, Fujita T, Yasugi T.

Clin Exp Immunol. 1992 Sep;89(3):479-84.

PMID:
1516262
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

MPGN II--genetically determined by defective complement regulation?

Licht C, Schlötzer-Schrehardt U, Kirschfink M, Zipfel PF, Hoppe B.

Pediatr Nephrol. 2007 Jan;22(1):2-9. Epub 2006 Sep 23.

PMID:
17024390
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk